| Name | Kohlls Rx |
|---|---|
| Organization Name | Sakrx Llc |
| Location | 2915 Leavenworth St, Omaha, Nebraska 68105 |
| Type | Pharmacy |
| Phone | (402) 342-6548 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
The Pharmacy Benefit Management Institute (PBMI) recently released the results of its 2009 Pharmacy Benefit Management Customer Satisfaction Report and Envision Pharmaceutical Services, Inc. received the highest overall customer scores for the second straight year.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
› Verified 3 days ago
| NPI Number | 1215402250 |
| Organization Name | SAKRX, LLC |
| Doing Business As | KOHLL'S RX |
| Type | Pharmacy |
| Address | 2915 Leavenworth St, Omaha, NE 68105 |
| Phone Number | 402-342-6548 |
News Archive
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
The Pharmacy Benefit Management Institute (PBMI) recently released the results of its 2009 Pharmacy Benefit Management Customer Satisfaction Report and Envision Pharmaceutical Services, Inc. received the highest overall customer scores for the second straight year.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
› Verified 3 days ago
| NPI Number | 1487129425 |
| Organization Name | SAKRX, LLC |
| Doing Business As | KOHLL'S RX |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2915 Leavenworth St, Omaha, NE 68105 |
| Phone Number | 402-342-6548 |
News Archive
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
The Pharmacy Benefit Management Institute (PBMI) recently released the results of its 2009 Pharmacy Benefit Management Customer Satisfaction Report and Envision Pharmaceutical Services, Inc. received the highest overall customer scores for the second straight year.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
› Verified 3 days ago
| NPI Number | 1811510589 |
| Organization Name | SAKRX, LLC |
| Type | Long Term Care Pharmacy |
| Address | 2915 Leavenworth St, Omaha, NE 68105 |
| Phone Number | 402-342-6548 |
News Archive
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
The Pharmacy Benefit Management Institute (PBMI) recently released the results of its 2009 Pharmacy Benefit Management Customer Satisfaction Report and Envision Pharmaceutical Services, Inc. received the highest overall customer scores for the second straight year.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
› Verified 3 days ago
News Archive
Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.
The Pharmacy Benefit Management Institute (PBMI) recently released the results of its 2009 Pharmacy Benefit Management Customer Satisfaction Report and Envision Pharmaceutical Services, Inc. received the highest overall customer scores for the second straight year.
Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.
› Verified 3 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10156 L St, Omaha, Nebraska 68127 Phone: (402) 731-8700 | |
Redlers Ltc Pharmacy Type: Pharmacy Location: 13831 Chalco Valley Pkwy, Omaha, Nebraska 68138 Phone: (402) 592-5244 | |
Amber Pharmacy Type: Medicare Supplier Location: 10004 S 152nd Street, Omaha, Nebraska 68138 Phone: (402) 896-5000 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8310-8314 F Street, Omaha, Nebraska 68127 Phone: (402) 331-7100 |